-
Views
-
Cite
Cite
Andreas H. Groll, Neelam Giri, Vidmantas Petraitis, Ruta Petraitiene, Myrna Candelario, John S. Bacher, Stephen C. Piscitelli, Thomas J. Walsh, Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System, The Journal of Infectious Diseases, Volume 182, Issue 1, July 2000, Pages 274–282, https://doi.org/10.1086/315643
- Share Icon Share
Abstract
The central nervous system (CNS) distribution and antifungal efficacy of all 4 approved formulations of amphotericin B (AmB) were investigated in a rabbit model of hematogenous Candida albicans meningoencephalitis. Treatment with AmB deoxycholate (1 mg/kg/day) or liposomal AmB (5 mg/kg/day) yielded the highest peak plasma concentration (Cmax), area under concentration versus time curve from zero to 24 h (AUC0–24), and time during dosing level τ (Tτ) > minimum inhibitory complex (MIC) values and led to complete eradication of C. albicans from brain tissue (P < .05 vs. untreated controls). By comparison, AmB colloidal dispersion and AmB lipid complex (5 mg/kg/day each) were only partially effective (not significant vs. untreated controls). There was a strong correlation of Cmax, AUC0–24, Cmax/MIC, AUC0–24/MIC, and Tτ>MIC with clearance of C. albicans from brain tissue (P ⩾ .0002). Although pharmacodynamic parameters derived from the MIC of free AmB were highly predictive of antifungal efficacy, parameters derived from MICs of individual formulations were not predictive. AmB deoxycholate and liposomal AmB had the greatest antifungal efficacy. This activity was concentration and time dependent.